Cardiac risk assessment before the use of stimulant medications in children and youth: A joint position statement by the Canadian Paediatric Society, the Canadian Cardiovascular Society and the Canadian Academy of Child and Adolescent Psychiatry

Journal of the Canadian Academy of Child and Adolescent Psychiatry

Volumn 18, Issue 4, 2009, Pages 349-355

  Hamilton, R ^a   Gray, C ^b   Belanger S A ^c   Warren, A E ^d   Gow, R M ^b   Sanatani, S ^e   Cote J M ^f   Lougheed, J ^b   LeBlanc, J ^d   Martin, S ^g   Miles, B ^h   Mitchell, C ⁱ   Gorman, D A ^a   Weiss, M ^e   Schachar, R ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^c UNIVERSITY OF MONTREAL   (Canada)

^d DALHOUSIE UNIVERSITY   (Canada)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f LAVAL UNIVERSITY   (Canada)

^g Royal Alexandra Hospital   (Canada)

^h Dufferin Peel CDSB   (Canada)

ⁱ Ministry of Children and Youth Services Child and Parent Resource Institute   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL STIMULANT AGENT; METHYLPHENIDATE;

ARTICLE; ATTENTION DEFICIT DISORDER; CARDIOVASCULAR RISK; CARDIOVASCULAR SYSTEM EXAMINATION; CAREGIVER BURDEN; CHILD; CHILD CARE; CHILD DEATH; CONSULTATION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG FATALITY; DRUG SAFETY; DRUG USE; ELECTROCARDIOGRAPHY; HEALTH CARE COST; HEART ARRHYTHMIA; HEART DISEASE; HEART SURGERY; HIGH RISK POPULATION; HUMAN; MORTALITY; PHYSICAL EXAMINATION; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SUDDEN DEATH;

EID: 71949086277     PISSN: 17198429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. American Academy of Pediatrics, Subcommittee of Attention-Deficit/ Hyperactivity Disorder and Committee on Quality Improvement (2001). Clinical practice guideline: treatment of the school-aged child with attention-deficit/ hyperactivity disorder. Pediatrics, 108(4), 1033-1044
2. American Academy of Pediatrics/American Heart Association (2008). American Academy of Pediatrics/American Heart Association clarification of statement on cardiovascular evaluation and monitoring of children and adolescents with heart disease receiving medications for ADHD: May 16, 2008. Journal of Developmental and Behavioral Pediatrics, 29, 335.
3. Bar-Cohen, Y., & Silka, M. J. (2008). Sudden Cardiac death in Pediatrics. Current Opinions in Pediatrics, 20, 517-521
4. Barkley, R. A., Murphy, K. R, & Kwasnik, D. (1996). Motor vehicle driving competencies and risks in teens and young adults with attention deficit hyperactivity disorder. Pediatrics, 98, 1089-1095
5. Barkley, R. A. (1998). Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment 2nd Edition. New York: Guilford Publications, Inc, 197.
6. Berger, S., Kugler, J. D., Thomas, J. A., & Friedberg, D. Z. (2004). Sudden Cardiac Death in Children and Adolescents: Introduction and Overview. In: Stuart Berger, ed. Sudden Cardiac Death in Children and Adolescents. Pediatric Clinics of North America, 51, 1201-1209.
7. Berger, S., Utech, L., & Hazinski, M. F. (2004). Sudden death in children and adolescents. Pediatric Clinics of North America, 51, 1653-1677
8. Biederman, J., Wilens, T., Mick, E., Spencer, T., & Faraone, V. (1999). Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder. Pediatrics, 104, e20.
9. Brown, R. T, & Pacini, J. N. (1989). Perceived family functioning, marital status, and depression in parents of boys with attention deficit disorder. Journal of Learning Disabilities, 22, 581-587
10. Campbell, R. M., & Berger, S. (2006). Preventing pediatric sudden cardiac death: Where do we start? Pediatrics, 118, 802-804
11. Cohen, A., Jhung, M., & Budnitz, D. (2006). Stimulant Medications and Attention Deficit-Hyperactivity Disorder. New England Journal of Medicine, 354, 2294-2295 (Pubitemid 43788161)
12. Conway, J., Wong, K. K., O'Connell, C., & Warren, A. E. (2008). Cardiovascular risk screening before starting stimulant medications and prescribing practices of Canadian physicians: impact of the Health Canada advisory. Pediatrics, 122, e828-34.
13. Corrado, D., Basso, C., Schiavon, M., & Thiene, G. (1998). Screening for hypertrophic cardiomyopathy in young athletes. New England Journal of Medicine, 339, 364-369 (Pubitemid 28363798)
14. Corrado, D., Basso, C., Pavei, A., Michieli, P., Schiavon, & M., Thiene, G. (2006). Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. Journal of the American Medical Association, 296, 1593-1601. (Pubitemid 44515020)
15. Dancea, A., Côté, A., Rohlicek, C., Bernard, C., & Oligny, L. L. (2002). Cardiac pathology in sudden unexpected infant death. Journal of Pediatrics, 141, 336-342 (Pubitemid 35041922)
16. Frohna, J. G. (2007). A preparticipation screening program can decreased the incidence of sudden cardiac death among young athletes. Journal of Pediatrics, 150, 319-320
17. Fuller, C. (2000). Cost effectiveness analysis of screening of high school athletes for risk of sudden cardiac death. Medical Science in Sports Exercise, 32, 887-890
18. Gelperin, K., Benoit, S., & Pamer, C. (2006). Review of AERS data for marketed safety experience during stimulant therapy: death, sudden death, cardiovascular SAEs (including stroke). http://www.fda.gov/ohrms/dockets/ac/06/ briefing/2006-4202B1-05-FDA-Tab05.pdf (Version current at August 10, 2009).
19. Goldman, L. S., Genel, M., Bezman, R. J., & Slanetz, P. J. (1998). Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association. Journal of the American Medical Association, 279, 1100-1107
20. Gould, M. S., Walsh, B. T., Munfakh, J. L., et al. (2009). Sudden death and use of stimulant medications in youths. American Journal of Psychiatry, Epub, June 15, 2009, doi:10.1176/appi.ajp.2009.09040538.
21. Greenhill, L. L. (1998). Diagnosing attention-deficit/hyperactivity disorder in children. Journal of Clinical Psychiatry, 59 (Suppl 7), 31-41.
22. Health Canada (2006). Updating of Product Monograph of Attention Deficit Hyperactivity Disorder (ADHD) Drugs - For Health Professionals. 〈http://www.hc-sc.gc.ca/dhp-mps/medef f/advisories-avis/prof/-2006/adhd- tdah-medic-hpc-cps-eng.php〉 (Version current at August 10, 2009).
23. Hovels-Gurich, H. H., Konrad, K., Skorzenski, D., et al. (2006). Long term neurodevelopmental outcomes and exercise capacity after corrective surgery for tetralogy of Fallot or VSD in infancy. Annals of Thoracic Surgery, 83, 958-966 (Pubitemid 43247667)
24. Neuspiel, D. R., & Kuller, L. H. (1985). Sudden and unexpected natural death in childhood and adolescence. Journal of the American Medical Association, 254, 1321-1325 (Pubitemid 15236604)
25. Niemenen, H., Jokinen, E., & Sairanen, H. (2007). Causes of late deaths after pediatric surgery: a population based study. Journal of the American College of Cardiology, 50, 1263-1271 (Pubitemid 47405126)
26. Perrin, J. M., Friedman, R. A., & Knilans, T. K. (2008). Black Box Working Group, Section on Cardiology and Cardiac Surgery. Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder. Pediatrics, 122, 451-453
27. Racoosin, J. (2006). Follow up review of AERS search identifying cases of sudden death occurring with drugs used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). http://www.fda.gov/ohrms/dockets/ac/06/briefing/ 2006-4210b-07-01-safetyreview.pdf (Version current at August 10, 2009).
28. Sanatani, S., Wilson, G., Smith, C. R., Hamilton, R. M., Williams, W. G., & Adatia, I. (2006). Sudden unexpected death in children with heart disease. Congenital Heart Disease, 1, 89-97. (Pubitemid 43805649)
29. Shillingford, A. J., Glanzman, M. M., Ittenbach, R. F., Clancy, R. R., Gaynor, J. W., & Wernovsky, G. (2008). Inattention, hyperactivity, and school performance in a population of school-age children with complex congenital heart disease. Pediatrics, 121, e759-67.
30. Silka, M., Hardy, B., Menashe, V., & Morris, C. (1998). A population-based prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects. Journal of the American College of Cardiology, 32, 245-251 (Pubitemid 28351069)
31. Slomkowski, C., Klein, R. G., & Mannuzza, S. (1995). Is self-esteem an important outcome in hyperactive children? Journal of Abnormal Child Psychology, 23, 303-315
32. Stein, M. A., Szumowski, E., Blondis, T. A., & Roizen, N. J. (1995). Adaptive skills dysfunction in ADD and ADHD children. Journal of Child Psychology and Psychiatry, 36, 663-670
33. Tanaka, Y., Yoshinaga, M., Anan, R., et al. (2006). Usefulness and cost effectiveness of cardiovascular screening of young adolescents. Medical Science in Sports Exercise, 38, 2-6. (Pubitemid 43062949)
34. U.S. Food and Drug Administration, Drug Safety and Risk Management Advisory Committee (2006). www.fda.gov/oc/advisory/accalendar/2006/ cder12535dd02091006.html (Version current at August 10, 2009).
35. U.S. Food and Drug Administration (2009). Communication about an Ongoing Safety Review of Stimulant Medications used in Children with Attention-Deficit/Hyperactivity Disorder (ADHD). http://www.fda.gov/Drugs/ DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ DrugSafetyInformationforHeathcareProfessionals/ucm165858.htm (Version current at August 10, 2009).
36. Vetter, V. L., Elia, J., Erickson, C., et al. (2008). Cardiovascular monitoring of children and adolescents with heart disease receiving stimulant drugs: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing. Circulation, 117, 2407-2423 (Pubitemid 351653546)
37. Winterstein, G., Gerhard, T., Shuster, J., Johnson, M., Zito, J. M., & Saidi, A. (2007). Cardiac safety of central nervous system stimulants in children and adolescents with attention-deficit/hyperactivity disorder. Pediatrics, 120, e1494-501.
38. Wisten, A., & Messner, T. (2005). Symptoms preceding sudden cardiac death in the young are common but often misinterpreted. Scandinavian Cardiovascular Journal, 39, 143-149 (Pubitemid 41657524)
39. Wren, C., O'Sullivan, J. J., & Wright, C. (2000). Sudden death in children and adolescents. Heart, 83, 410-413